Micosis sistémicas en pacientes inmunocomprometidos

Ruiz-Camps, 2013, Síndrome de la enfermedad fúngica invasora, 811

Moreno, 2012, Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study, Liver Transplant., 18, 70, 10.1002/lt.22431

Springer, 2012, Molecular techniques in the diagnosis of deep and systemic mycosis, Clin Dermatol., 30, 651, 10.1016/j.clindermatol.2012.01.009

Samarakoon, 2008, Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature, Chron Respir Dis., 5, 19, 10.1177/1479972307085637

Fortún, 2011, [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update], Enferm Infecc Microbiol Clin., 29, 435, 10.1016/j.eimc.2011.01.010

Celi, 2015

Stevens, 2000, A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis, NEngl J Med., 342, 756, 10.1056/NEJM200003163421102

Ausina Ruiz, 2005

Fernández-Ruiz, 2012, Aspergillus tracheobronchitis: report of 8 cases and review of the literature, Medicine (Baltimore)., 91, 261, 10.1097/MD.0b013e31826c2ccf

Kousha, 2011, Pulmonary aspergillosis: a clinical review, Eur Respir Rev Off J Eur Respir Soc., 20, 156, 10.1183/09059180.00001011

Denning, 2016, Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management, Eur Respir J., 47, 45, 10.1183/13993003.00583-2015

Smith, 2011, Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma, Eur Respir J., 37, 865, 10.1183/09031936.00054810

Ader, 2009, Management of invasive aspergillosis in patients with COPD: rational use of voriconazole, Int J Chron Obstruct Pulmon Dis., 4, 279, 10.2147/COPD.S4229

Georgiadou, 2011, The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts, Clin Infect Dis., 52, 1144, 10.1093/cid/cir122

Parrón, 2008, The halo sign in computed tomography images: differential diagnosis and correlation with pathology findings, Arch Bronconeumol., 44, 386, 10.1016/S0300-2896(08)70453-8

Luong, 2011, Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients, Clin Infect Dis., 52, 1218, 10.1093/cid/cir185

Gruson, 2000, Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates, Crit Care Med., 28, 2224, 10.1097/00003246-200007000-00007

Ascioglu, 2002, Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus, Clin Infect Dis., 34, 7, 10.1086/323335

Groll, 2009, Recent advances in antifungal prevention and treatment, Semin Hematol., 46, 212, 10.1053/j.seminhematol.2009.03.003

Cornely, 2007, Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia, NEngl J Med., 356, 348, 10.1056/NEJMoa061094

Ruiz-Camps, 2010, Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi], Enferm Infecc Microbiol Clin., 28

Patterson, 2000, Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group, Medicine (Baltimore)., 79, 250, 10.1097/00005792-200007000-00006

Marr, 2015, Combination antifungal therapy for invasive aspergillosis: a randomized trial, Ann Intern Med., 162, 81, 10.7326/M13-2508

Patterson, 2016, Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis., 63, e1, 10.1093/cid/ciw326

Cuenca-Estrella, 2009, Incidence of zygomycosis in transplant recipients, Clin Microbiol Infect Dis., 15 Suppl 5, 37, 10.1111/j.1469-0691.2009.02978.x

ucci, 2007, Fusarium infections in immunocompromised patients, Clin Microbiol Rev., 20, 695, 10.1128/CMR.00014-07

Kratzer, 2006, In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp, J Antimicrob Chemother., 58, 1058, 10.1093/jac/dkl384

Sun, 2011, Mucormycosis: its contemporary face and management strategies, Lancet Infect Dis., 11, 301, 10.1016/S1473-3099(10)70316-9

Colombo, 2011, Current knowledge of Trichosporon spp. and Trichosporonosis, Clin Microbiol Rev., 24, 682, 10.1128/CMR.00003-11

Ruiz Camps, 2016, Invasive yeast infections in neutropenic patients], Rev Iberoam Micol., 33, 170, 10.1016/j.riam.2015.11.001

Muñoz, 2005, Saccharomyces cerevisiae fungemia: an emerging infectious disease, Clin Infect Dis., 40, 1625, 10.1086/429916